연구동향 분석
박사

Identification of candidate biomarkers for early diagnosis of oral squamous cell carcinoma : 구강편평상피세포암종의 조기 진단을 위한 후보 생체지표의 규명

김용덕 2015년

논문상세정보
인용/피인용
' Identification of candidate biomarkers for early diagnosis of oral squamous cell carcinoma : 구강편평상피세포암종의 조기 진단을 위한 후보 생체지표의 규명' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • biomarker
  • gene expression profiling
  • microarray
  • oral squamous cell carcinoma
  • quantitative reverse transcription polymerase chain reaction
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
378 0

0.0%

' Identification of candidate biomarkers for early diagnosis of oral squamous cell carcinoma : 구강편평상피세포암종의 조기 진단을 위한 후보 생체지표의 규명' 의 참고문헌

  • da Silva SD, Ferlito A, Takes RP, Brakenhoff RH, Valentin MD, Woolgar JA, et al. Advances and applications of oral cancer basic research. Oral Oncol. 2011;47:783-91.
  • Ziober AF, Patel KR, Alawi F, Gimotty P, Weber RS, Feldman MM, et al. Identificationof a gene signature for rapid screening of oral squamous cell carcinoma. Clin CancerRes. 2006;12:5960-71.
  • Zhong JL, Poghosyan Z, Pennington CJ, Scott X, Handsley MM, Warn A, et al. Distinctfunctions of natural ADAM-15 cytoplasmic domain variants in human mammarycarcinoma. Mol Cancer Res. 2008;6:383-94.
  • Zhao J, Rycaj K, Geng S, Li M, Plummer JB, Yin B, et al. Expression of humanendogenous retrovirus type K envelope protein is a novel candidate prognostic markerfor human breast vancer. Genes Cancer. 2011;2:914-22.
  • Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32-5.
  • Yin J, Tian L. Optimal linear combinations of multiple diagnostic biomarkers based onYouden index. Stat Med. 2014;33:1426-40.
  • Yang Y, Pospisil P, Iyer LK, Adelstein SJ, Kassis AI. Integrative genomic data miningfor discovery of potential blood-borne biomarkers for early diagnosis of cancer. PLOSone. 2008;3:e3661.
  • Yang Y, Bai J, Shen R, Brown SA, Komissarova E, Huang Y, et al. Polo-like kinase 3functions as a tumor suppressor and is a negative regulator of hypoxia-inducible factor-28 -1 alpha under hypoxic conditions Cancer Res. 2008;1;68(11):4077-85.
  • Yakob M, Fuentes L, Wang MB, Abemayor E, Wong DT. Salivary biomarkers fordetection of oral squamous cell carcinoma ? current state and recent advances. CurrOral Health Rep. 2014; 1;1(2):133-41.
  • Ungerer C, Doberstein K, Burger C, Hardt K, Boehncke WH, Bohm B, et al. ADAM15expression is downregulated in melanoma metastasis compared to primary melanoma. Biochem Biophys Res Commun. 2010;401:363-9.
  • Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to theionizing radiation response. Proc Natl Acad Sci. 2001;98:5116-21.
  • Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, et al. Clinicalimpact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg,th17) in patients with colorectal cancer. Cancer Res. 2011;71:1263-71.
  • Toquet C, Colson A, Jarry A, Bezieau S, Volteau C, Boisseau P, et al. ADAM15 toalpha5beta1 integrin switch in colon carcinoma cells: a late event in cancer progressionassociated with tumor dedifferentiation and poor prognosis. Int J Cancer. 2012;130:278-87.
  • Tenca P, Brotherton D, Montagnoli A, Rainoldi S, Albanese C, Santocanale C. Cdc7 isan active kinase in human cancer cells undergoing replication stress. J Biol Chem. 2007;282:208-15.
  • Takai N, Hamanaka R, Yoshimatsu J, Miyakwa I. Polo-like kinases (Plks) and cancer. Oncogene. 2005; 24(2): 287-291.
  • Supic G, Kozomara R, Jovic N, Zeljic K, Magic Z. Prognostic significance of tumorrelatedgenes hypermethylation detected in cancer-free surgical margins of oralsquamous cell carcinomas. Oral Oncol. 2011;47:702-8.
  • Slebos RJ, Yi Y, Ely K, Carter J, Evjen A, Zhang X, et al. Gene expression differencesassociated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res. 2006;12:701-9.
  • Shapiro SS, Wilk MB. An analysis of variance test for normality (complete samples). Biometrika. 1965;52:591-611.
  • Rodriguez-Acebes S, Proctor I, Loddo M, Wollenschlaeger A, Rashid M, Falzon M, etal. Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53-mutantbreast cancers. Am J Patho. 2010;177:2034-45.
  • Rodini CO, Xavier FC, Paiva KB, De Souza MF, Moyses RA, Michaluarte P, et al. Homeobox gene expression profile indicates HOXA5 as a candidate prognostic markerin oral squamous cell carcinoma. Int J Oncol . 2012;40(4): 1180-8.
  • Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, et al. Evidencebasedclinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc. 2010;141(5):509-20.
  • Rao SK, Pavicevic Z, Du Z, Kim JG, Fan M, Jiao Y, et al. Pro-inflammatory genes asbiomarkers and therapeutic targets in oral squamous cell carcinoma. J Biol Chem. 2010;285:32512-21.
  • Pistoia V, Cocco C, Airoldi I. Interleukin-12 receptor beta2: from cytokine receptor togatekeeper gene in human B-cell malignancies. J Clin Oncol. 2009;27:4809-16.
  • Pettus JR, Johnson JJ, Shi Z, Davis JW, Koblinski J, Ghosh S, et al. Multiple kallikrein(KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity. HistolHistopathol. 2009;24:197- 207.
  • Pereira JS, Monteiro BV, Nonaka CF, Silveira EJ, Miguel MC. FoxP3(+) T regulatorycells in oral lichen planus and its correlation with the distinct clinical appearance of thelesions. Int J Exp Pathol 2012; 93: 287-94.
  • Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533-43.
  • Oliver AW, He X, Borthwick K, Donne AJ, Hampson L, Hampson IN. The HPV16 E6binding protein Tip-1 interacts with ARHGEF16, which activates Cdc42. Br J Cancer. 2011;104:324-31.
  • Oflazoglu E, Grewal IS, Gerber H. Targeting CD30/CD30L in oncology andautoimmune and inflammatory diseases. Adv Exp Med Biol. 2009;647: 174-85.
  • Ni YH, Ding L, Hu QG, Hua ZC. Potential biomarkers for oral squamous cell carcinoma:proteomics discovery and clinical validation. Proteomics Clin Appl. 2015;9(1-2):86-97
  • Neville BW. Oral and Maxillofacial Pathology, Saunders/Elsevier: 2002; 356-67.
  • Montebugnoli L, Gissi DB, Marchetti C, Foschini MP. Multiple squamous cellcarcinomas of the oral cavity in a young patient with graft-versus-host diseasefollowing allogenic bone marrow transplantation. Int J Oral Maxillofac Surg 2011; 40:556-8.
  • Montagnoli A, Moll J, Colotta F. Targeting cell division cycle 7 kinase: a newapproach for cancer therapy. Clin Cancer Res. 2010;16:4503-8.
  • Menendez ST, Rodrigo JP, Allonca E, Garcia-Carracedo D, Alvarez- Alija G, Casado-Zapico S, et al. Expression and clinical significance of the Kv3.4 potassium channelsubunit in the development and progression of head and neck squamous cell carcinomas. J Pathol. 2010;221:402-10.
  • Mendez E, Cheng C, Farwell DG, Ricks S, Agoff SN, Futran ND, et al. Transcriptionalexpression profiles of oral squamous cell carcinomas. Cancer. 2002;95:1482-94.
  • McLeod NM, Saeed NR, Ali EA. Oral cancer: Delays in referral and diagnosis persist. Br Dent J. 2005;198:681-84.
  • Marenholz I, Rivera VA, Esparza-Gordillo J, Bauerfeind A, Lee-Kirsch MA,Ciechanowicz A, et al. Association screening in the Epidermal Differentiation Complex(EDC) identifies an SPRR3 repeat number variant as a risk factor for eczema. J InvestDermatol.2011;131:1644-9.
  • Mao L, Hong WK, Papadimitrakopoulou VA. Focus on head and neck cancer. CancerCell. 2004; 5(4): 311-16.
  • Lucas N, Najy AJ, Day ML. The therapeutic potential of ADAM15. Currentpharmaceutical design. 2009;15:2311-8.
  • Longoni M, Orzan F, Stroppi M, Boari N, Mortini P, Riva P. Evaluation of 1p36markers and clinical outcome in a skull base chordoma study. Neuro Oncol. 2008;10:52-60.
  • Lockstone HE. Exon array data analysis using Affymetrix power tools and R statisticalsoftware. Brief Bioinform. 2011;12:634-44.
  • Li B, Ouyang B, Pan H, Reissmann PT, Slamon DJ, Arceci R, et al. Prk, a cytokineinduciblehuman protein serine/threonine kinase whose expression appears to be downregulatedin lung carcinomas. J Biol Chem. 1996;271:19402-8.
  • Lenain C, Bauwens S, Amiard S, Brunori M, Giraud-Panis MJ, Gilson E. The Apollo 5’exonuclease functions together with TRF2 to protect telomeres from DNA repair. CurrBiol. 2006;16:1303-10.
  • Kuwano Y, Kamio Y, Kawai T, Katsuura S, Inada N, Takaki A, et al. Autism-associatedgene expression in peripheral leucocytes commonly observed between subjects withautism and healthy women having autistic children. PLOS one. 2011;6:e24723.
  • Kulkarni AA, Kingsbury SR, Tudzarova S, Hong HK, Loddo M, Rashid M, et al. Cdc7kinase is a predictor of survival and a candidate therapeutic target in epithelial ovariancarcinoma. Clin Cancer Res. 2009;15:2417-25.
  • Kang MR, Kang JS, Yang JW, Kim BG, Kim JA, Jo YN, et al. Gene expressionprofiling of KBH-A42, a candidate histone deacetylase inhibitor, in human leukemia andbladder cancer cell lines. Oncol Lett. 2012;3:113-8.
  • Jeon SH. Potential of interleukin 12, beta 2 subunit (IL12RB2) and tumor necrosisfactor superfamily, member 8 (TNFRSF8) gene as diagnostic biomarkers of oral lichenplanus. Doctor’s thesis of Seoul National University. 2014
  • Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CACancer J Clin. 2008;58:71-96.
  • Jain N, Thatte J, Braciale T, Ley K, O’Connell M, Lee JK. Local- pooled-error test foridentifying differentially expressed genes with a small number of replicated microarrays. Bioinformatics. 2003;19:1945-51.
  • Harris MJ, Arias IM. FIC1, a P-type ATPase linked to cholestatic liver disease, hashomologues (ATP8B2 and ATP8B3) expressed throughout the body. Biochim BiophysActa. 2003;1633:127-31.
  • Gasche JA, Hoffmann J, Boland CR, Goel A. Interleukin-6 promotes tumorigenesis byaltering DNA methylation in oral cancer cells. Int J Cancer. 2011;129:1053-63.
  • Durkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H. Molecular cloning andexpression of a new member of the nerve growth factor receptor family that ischaracteristic for Hodgkin’s disease. Cell. 1992;68:421-7.
  • Duffy MJ, McKiernan E, O’Donovan N, McGowan PM. Role of ADAMs in cancerformation and progression. Clin Cancer Res. 2009;15:1140-4.
  • Cheong SC, Chandramouli GV, Saleh A, Zain RB, Lau SH, Sivakumaren S, et al. Geneexpression in human oral squamous cell carcinoma is influenced by risk factor exposure. Oral Oncol. 2009;45:712-9.
  • Chen C, Mendez E, Houck J, Fan W, Lohavanichbutr P, Doody D, et al. Geneexpression profiling identifies genes predictive of oral squamous cell carcinoma. CancerEpidemiol Biomarkers Prev. 2008;17:2152-62.
  • Cardenes M, Angel Moreno A, Fieschi C, Soloquren I, Colino E, Molines A, et al. Oesophageal squamous cell carcinoma in a young adult with IL-12R beta 1 deficiency. JMed Genet. 2010;47(9):635-7
  • Bassuny WM, Ihara K, Kimura J, Ichikawa S, Kuromaru R, Miyako K, et al. Association study between interleukin-12 receptor beta1/beta2 genes and type 1 diabetesor asthma in the Japanese population. Immunogenetics. 2003;55:189-92.
  • Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103: Suppl. (S25): e1-12.
  • Airoldi I, Di Carlo E, Cocco C, Sorrentino C, Fais F, Cilli M, et al. Lack of Il12rb2signaling predisposes to spontaneous autoimmunity and malignancy. Blood. 2005;106:3846-53.
  • Ahn SM, Kim TH, Lee S, Kim D, Ghang H, Kim DS, et al. The first Korean genomesequence and analysis: full genome sequencing for a socio-ethnic group. Genome Res. 2009;19:1622-9.
  • Agnelli L, Mereu E, Pellegrino E, Limongi T, Kwee I, Bergaggio E, et al. (European TCellLymphoma Study Group) Identification of a three-gene model as a powerfuldiagnostic tool for the recognition of ALK negative ALCL. Blood. 2012;120:1274-81.